Through its innovative value adding nature, Final entered the pharmaceuticals industry with the aim of producing affordable pharmaceuticals and medicines of world class standard in Mozambique. In 1999 Final Farmaceutica was created as a division of Final Investment to build, develop and manage Mozambique’s first Intravenous (IV) solutions production plant in Matola. Final built and managed the state-of-the-art plant producing IV fluids which were procured by the Mozambican state with the aim of expanding these affordable medicines to the Mozambican people as well as to neighbouring country. The IV solutions plant was sold to the Mozambican State in 2009, Final Farmaceutica still continues to trade in “over the counter” pharmaceuticals and medicines through partnerships and agreements with other pharmaceutical companies in Africa.


Final is a privately owned investments holding company based in Maputo, Mozambique primarily focused on financing, investment, trading and representation (agency). Established in 1992 Final was one of the first of its kind in Mozambique undertaking various projects and assignments which have brought long-term value to its stakeholders, clients and partners.

Contact us

Final – Financiamentos, Investimentos e Agenciamentos Lda| Av. 25 de Setembro nº 2826 Maputo, Moçambique Telefax: (+258) 21 492078 Email: